PINK | Jotup

BBX Capital, Inc. Announces Preliminary Results of Tender Offer

Retrieved on:

Thursday, December 21, 2023

Based on the preliminary count by Equiniti Trust Company, LLC, the Depositary for the tender offer, a total of 737,134 shares of BBX Capital’s Class A Common Stock were properly tendered and not withdrawn.

Key Points:

Based on the preliminary count by Equiniti Trust Company, LLC, the Depositary for the tender offer, a total of 737,134 shares of BBX Capital’s Class A Common Stock were properly tendered and not withdrawn.
In accordance with the terms and conditions of the tender offer, including the Company’s right to accept the tender of additional shares up to an amount equal to two percent of the outstanding shares of the Company’s Class A Common Stock outstanding upon the commencement of the tender offer, the Company will purchase 726,043 shares in the tender offer.
It is expected that the final results of the tender offer will be announced and payment for shares accepted in the tender offer will commence by Wednesday, December 27, 2023.
Shareholders who have questions or would like additional information about the tender offer may contact the Information Agent for the tender offer, MacKenzie Partners, Inc., toll-free at (800) 322-2885.

BBX Capital Announces Intention to Commence a Cash Tender Offer for Shares of its Class A Common Stock

Retrieved on:

Wednesday, November 15, 2023

If more than 500,000 shares are tendered in the tender offer, then, subject to the terms and conditions of the tender offer, the Company will purchase shares from shareholders who properly tender shares on a pro rata basis based on the aggregate number of shares tendered.

Key Points:

If more than 500,000 shares are tendered in the tender offer, then, subject to the terms and conditions of the tender offer, the Company will purchase shares from shareholders who properly tender shares on a pro rata basis based on the aggregate number of shares tendered.
The terms and conditions of the tender offer will be described in an offer to purchase and related letter of transmittal that will be mailed to the Company’s shareholders shortly after commencement of the tender offer.
None of the Company or its Board of Directors, the Information Agent for the tender offer or the Depositary for the tender offer will make any recommendation to shareholders as to whether to tender or refrain from tendering their shares in the tender offer.
If the tender offer is commenced, the Company will also file a Tender Offer Statement on Schedule TO (the “Tender Offer Statement”) with the Securities and Exchange Commission (the “SEC”), which will include as exhibits, among other things, the offer to purchase and related letter of transmittal and other tender offer materials.

Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas with Follow-On Placement of Perimeter S-Series OCT within National Healthcare Provider System

Retrieved on:

Thursday, December 14, 2023

S series, FSE, MRI, OTC, Optical coherence tomography, PINK, OCT, Perimeter

DALLAS and TORONTO, Dec. 14, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced a follow-on commercial placement of its flagship Perimeter S-Series OCT system at a new hospital site within one of the largest healthcare networks in North Texas, which is part of a major national healthcare system.

Key Points:

DALLAS and TORONTO, Dec. 14, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced a follow-on commercial placement of its flagship Perimeter S-Series OCT system at a new hospital site within one of the largest healthcare networks in North Texas, which is part of a major national healthcare system.
Perimeter's flagship product, the S-Series OCT (Optical Coherence Tomography), is a pioneering medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room at 10 times higher image resolution than X-ray and ultrasound, and 100 times greater image resolution than MRI.
Adrian Mendes, Perimeter's Chief Executive Officer, stated, "We believe this additional commercial placement within a major national healthcare system – representing the fifth unit placed with this existing customer network – demonstrates that surgeon end users, as well as other stakeholders within the broader healthcare system, see the value of our technology and are recommending it to their peers.
Our aim is to make Perimeter's innovative technology the standard of care in cancer surgery."

Perimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on:

Tuesday, November 14, 2023

TORONTO and DALLAS, Nov. 14, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its third quarter ended September 30, 2023 and provided a corporate update.

Key Points:

TORONTO and DALLAS, Nov. 14, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its third quarter ended September 30, 2023 and provided a corporate update.
Based on feedback from the FDA, we successfully introduced improved AI into the ongoing clinical trial evaluating the use of Perimeter B-Series OCT combined with AI during breast conservation surgery.
Many physicians support our belief that combining AI with high-resolution imaging has the potential to become a new standard of care during breast conservation surgery."
The Company will host a conference call and live audio webcast today at 5:00 pm Eastern Time to discuss its third quarter 2023 results and to provide a corporate update.

BBX Capital, Inc. Reports Financial Results For the Third Quarter of 2023

Retrieved on:

Wednesday, November 8, 2023

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the third quarter of 2023.

Key Points:

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the third quarter of 2023.
The following selected information relates to the financial results of the Company’s principal holdings: BBX Capital Real Estate, BBX Sweet Holdings, and Renin.
In connection with the transition, BBX Sweet Holdings acquired his noncontrolling interest in IT’SUGAR, and as a result, IT'SUGAR became a wholly-owned subsidiary of BBX Sweet Holdings during the three months ended September 30, 2023.
As of September 30, 2023, Renin was current on the payment terms under its TD Bank credit facility.

Victoria’s Secret & Co. to Maximize Supplier Diversity Efforts through Unique Programs

Retrieved on:

Wednesday, November 8, 2023

NYSE, Hope, Veteran, VSCO, DEI, Partnership, Farmer, Art, Woman, VS, Disability, PINK, Renewable energy, Tourism

REYNOLDSBURG, Ohio, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (NYSE: VSCO) is proud to further its social impact and amplify its commitment to diversity, equity and economic empowerment through its unique partnerships and programs.

Key Points:

REYNOLDSBURG, Ohio, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (NYSE: VSCO) is proud to further its social impact and amplify its commitment to diversity, equity and economic empowerment through its unique partnerships and programs.
The cotton will begin to appear in the Victoria’s Secret and PINK product assortment in summer 2024.
The event at large underscores the company’s dedication to maintaining its commitments, as part of the Fifteen Percent Pledge.
To date, 66 percent of Victoria’s Secret’s market collection partners are found, owned or led by women.

BBX Capital, Inc. to Issue Financial Results for the Third Quarter of 2023 on November 8, 2023

Retrieved on:

Monday, October 30, 2023

Commercial Building & Real Estate, Construction & Property, Finance, Urban Planning, REIT, Professional Services, Interior Design, Building Systems, Other Construction & Property, Residential Building & Real Estate, BBX Capital Corporation, PINK, OTCQX, Rare-earth element, Cryptocurrency

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (the “Company”) announced today that the Company plans to release its financial results for the third quarter of 2023 in a press release to be issued after market close on Wednesday, November 8, 2023.

Key Points:

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (the “Company”) announced today that the Company plans to release its financial results for the third quarter of 2023 in a press release to be issued after market close on Wednesday, November 8, 2023.

Perimeter Medical Imaging AI Announces Initiation of New Clinical Trial Site at University of Washington/Fred Hutch Cancer Center

Retrieved on:

Tuesday, October 31, 2023

Hope, FSE, Perimeter, OTC, PINK, Trial of the century, University, Patient, MPD, Breast cancer, Pharmaceutical industry, Medical imaging, MD

DALLAS and TORONTO, Oct. 31, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the initiation of an additional clinical trial site at the University of Washington / Fred Hutch Cancer Center located in Seattle, WA.

Key Points:

DALLAS and TORONTO, Oct. 31, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the initiation of an additional clinical trial site at the University of Washington / Fred Hutch Cancer Center located in Seattle, WA.
Perimeter is conducting an ongoing multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined with its proprietary ImgAssist AI software when used during breast conservation surgeries.
Meghan R. Flanagan, MD, MPD, University of Washington/Fred Hutch Cancer Center stated, "Recognizing the unmet need in the field of breast cancer margin visualization, we are pleased to become the most recent site to participate in this clinical study.
Adrian Mendes, Perimeter's Chief Executive Officer stated, "We are focused on expediting the development of our next-gen AI technology and its clinical evaluation in an ongoing pivotal trial.

American Energy Partners, Inc. Announces the Signing of a Letter of Intent for a Reverse Merger With a Nasdaq Listed Company, SCWorx Corp.

Retrieved on:

Monday, October 23, 2023

AEPT, Security (finance), American Energy Partners, LP, Cyprus Securities and Exchange Commission, Acquisition, Biophysical environment, Transaction, North American Environmental Atlas, Bank statement, Growth, Letter of intent, LOI, PINK, Cryptocurrency, Audit

The binding components require among other things that American Environmental provide SCWorx $150,000 of working capital, as well as cover its costs to complete the Proposed Transaction.

Key Points:

The binding components require among other things that American Environmental provide SCWorx $150,000 of working capital, as well as cover its costs to complete the Proposed Transaction.
In addition, both parties are restricted from engaging in discussions with other parties about an acquisition or other transaction similar to the terms of the Proposed Transaction.
The Proposed Transaction has been approved by the Boards of Directors of both SCWorx and American Environmental and is expected to close in the first quarter of 2024.
It is truly the spark that ignites our potential for a brighter future.”
American Energy Partners, Inc. is a conglomerate holding company.

VS&Co Launches First-Ever VS & PINK Adaptive Collections

Retrieved on:

Tuesday, October 17, 2023

Certification, PINK, Collection, Disability, Marketing, VS, Secrecy, Victoria's Secret, Woman, Fashion design

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Today, Victoria's Secret and PINK announced the launch of VS & PINK Adaptive, their first-ever collections of intimates for women with disabilities. With the support of GAMUT Management (GAMUT), the premier consulting and talent management company working with and for people with disabilities. VS & PINK Adaptive was developed by incorporating direct feedback from people with disabilities throughout every step, including wear testing, focus groups, feedback panels and more. The collections are reflective of the company's mission to celebrate women of all body types, sizes and abilities, and it is proud to be the first major fashion brand to offer adaptive intimate products both online and in select stores.

Key Points:

VS & PINK Adaptive collections include beautifully constructed bras and panties that offer ease, comfort, and style for women with disabilities.
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Today, Victoria's Secret and PINK announced the launch of VS & PINK Adaptive, their first-ever collections of intimates for women with disabilities.
VS & PINK Adaptive was developed by incorporating direct feedback from people with disabilities throughout every step, including wear testing, focus groups, feedback panels and more.
VS Adaptive bras are available in cups B-G and bands 32-44, and VS Adaptive panties are available in XS-XXL.